| Trial ID: | L6553 |
| Source ID: | NCT01108978
|
| Associated Drug: |
Placebo
|
| Title: |
Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Cardiovascular Disease|Hypercholesterolemia
|
| Interventions: |
DRUG: Placebo|DRUG: Dehypotin
|
| Outcome Measures: |
Primary: Evaluation absolute and percentage reductions in low-density lipoprotein cholesterol (LDL-C) by fasting biochemistry examination, 12-week treatment | Secondary: Evaluation of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides by fasting biochemistry examination, 12-week treatment
|
| Sponsor/Collaborators: |
Sponsor: Nang Kuang Pharmaceutical Co., Ltd. | Collaborators: National Taiwan University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-05
|
| Completion Date: |
2011-05
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-09
|
| Locations: |
Nang Kuang Pharmaceutical Co., LTD, Tainan, Xinhua Township, 712, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01108978
|
